Keynote Speakers

Professor Anna Fagotti

Rome, Italy

  • Ovarian Cancer Unit Director at Fondazione Policlinico Universitario A. Gemelli IRCCS
  • Associate Professor of Obstetrics and Gynecology at Università Cattolica del Sacro Cuore
  • ESGO Council Member and Chair of the Educational Committee
  • Associate Editor of IJGC (International Journal of Gynecological Cancer)

Professor David Gaffney

Salt Lake City, USA

David Gaffney, MD, PhD, Senior Director of Clinical Research, is Professor and Vice-Chair of the University of Utah (U of U), Department of Radiation Oncology. Dr. Gaffney is a distinguished clinician and a long-standing leader in clinical research. Dr. Gaffney has led the NCTN Lead Academic Participant (NLAPs) grant at HCI since its initial award in 2013. He has held several national and international positions that have enabled him to leverage his passion for training and career development in Oncology. For a decade, he chaired the RTOG Working Group in gynecologic cancers. Dr. Gaffney was a long standing member of the NCI Gynecologic Cancer Steering Committee, and has completed his second 3 year term as a co-Chair of the NCI Gynecologic Cancer Steering Committee. Dr. Gaffney has been involved in global cooperative research for the past 14 years through the Gynecological Cancer Intergroup (GCIG). He served as a previous past chair of the cervix committee in the GCIG (2004-2008), and served as the first Chair the of the Cervix Cancer Research Network (CCRN) which was developed from activities at the GCIG. Dr. Gaffney is also a past president of the American Brachytherapy Society.

Dr Ana Oaknin

Barcelona, Spain

Doctor Ana Oaknin Benzaquen is Head of the Gynaecological Tumour Unit and full‐time Senior Attending Physician at Medical Oncology Department at the Vall d’Hebron University Hospital (HUVH). She is, as well, Principal Clinical Investigator of the Gynaecological Malignancies Group at the Vall d’Hebrón Institute of Oncology in Barcelona (VHIO).

Her main research interests are in angiogenesis, DNA repair mechanisms and immunology, and is Principal Investigator in several series of clinical trials in ovarian, cervical and endometrial cancer.

She is leading and involved in a large number of projects on gynaecological tumours. She is the author of over 100 publications and presentations in different Congress.

In addition, Dr. Oaknin is executive board member as a Co‐Chair of the GEICO Group (Spanish Ovarian Cancer Research Group), a faculty member for the Gyn‐Track in the European Society of Medical Oncology (ESMO), Subject Editor for Gynecological Malignancies in the ESMO Guidelines Committee, co‐Chair of the Cervical Committee of the GCIG Group and she is an active member of the American Society of Clinical Oncology (ASCO) and the Spanish Association of Medical Oncology (SEOM).

Key Dates

Sponsorship & Exhibition Prospectus
Now available

Now Open

Early Bird Registration Closes
13 February 2022